Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-07

Clinical Trial Update: Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of lumiracoxib in patients with osteoarthritis; the study including individuals with controlled hypertension ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumiracoxib (Prexige) (lumiracoxib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoarthritis, Controlled Hypertension | Phase 4 | Status: COMPLETED